2025

Packing lipid nanoparticles with tumor proteins to boost cancer vaccine potency

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, many therapeutic—as opposed to preventive—cancer vaccines have been in development, but none are approved. One hurdle is the difficulty in finding antigens in tumors that look foreign enough to trigger an immune response.

Read More
MRV News
Melanoma News
Archive
Menu